• gnutrino@programming.dev
    link
    fedilink
    English
    arrow-up
    14
    ·
    7 days ago

    For a start my understanding is that China doesn’t actually export much end product pharmaceuticals, it tends to export lots of the chemical precursors. So if companies moved their production to the US they would find that a large amount of the precursors they need now have 104% tariffs applied and they can’t compete with production in countries with less insane trade policies regardless of what tariffs go on the end products…